Post by marriott on Aug 18, 2023 21:18:25 GMT
A merger describes a story line where two companies link, and one of the companies is put out of existence by becoming part of the other company. These usually occur when the acquiring company is seeking business growth coupled with increasing market share , competitive advantages and gaining a more effective presence in the supply chain world. The fact that Novavax has not been publicly approached to date becomes much more understood. If you then say we do not if this is true, you would be correct. But again, the fact that there has been no merger to date results in the same understanding.
Firstly, yes I do agree that there will continued pressure on the Novavax share price due to the uncertainties of an evolving covid-related environment , Novavax-specific merger related disincentives and regulatory approvals in the United States.
During the last Call , Novavax advised us of their essential priorities going forward:
Priority #1: Deliver an Updated COVID Vaccine for the Upcoming 2023 Fall Vaccination Season
Priority #2: Reduce our Rate of Spend, Manage our Cash Flow and Evolve our Scale and Structure
Priority #3: Leverage our Technology Platform, our Capabilities and our Portfolio of Assets to Drive Additional Value Beyond Nuvaxovid Alone
Assuming the trajectory of the current Management priorities as stated above move forward with conviction , strength and confidence , there will result a much stronger business and financial asset!
I strongly believe that a merger may be forthcoming from a business entity domiciled from either Japan or South Korea. And I think this may happen within the next 18 months.